Clinical Trial Update: Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chemotherapy and monoclonal antibody therapy in patients with B-cell non-Hodgkin's lymphoma relapsed after peripheral stem cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Lymphoma | Phase 2 | Status: COMPLETED